20210106_Report538_Tofacitinib_ModeratetoSevereUlcerativeColitis.pdf
20210106_Report538_Tofacitinib_ModeratetoSevereUlcerativeColitis
Atualizado em
12/07/2022 15h01
20210106_Report538_Tofacitinib_ModeratetoSevereUlcerativeColitis.pdf